{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T06:52:43Z","timestamp":1782802363251,"version":"3.54.5"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,11,14]],"date-time":"2016-11-14T00:00:00Z","timestamp":1479081600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s00415-016-8333-7","type":"journal-article","created":{"date-parts":[[2016,11,14]],"date-time":"2016-11-14T06:33:26Z","timestamp":1479105206000},"page":"139-151","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration"],"prefix":"10.1007","volume":"264","author":[{"given":"Joachim","family":"Havla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"K\u00fcmpfel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Schinner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Spadaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Schuh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Meinl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Hohlfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Outteryck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,14]]},"reference":[{"key":"8333_CR1","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S1474-4422(15)00313-0","volume":"15","author":"R Hohlfeld","year":"2016","unstructured":"Hohlfeld R, Dornmair K, Meinl E, Wekerle H (2016) The search for the target antigens of multiple sclerosis, part 2: CD8+ T cells, B cells, and antibodies in the focus of reverse-translational research. Lancet Neurol 15:317\u2013331. doi: 10.1016\/S1474-4422(15)00313-0","journal-title":"Lancet Neurol"},{"key":"8333_CR2","doi-asserted-by":"publisher","unstructured":"Spadaro M, Gerdes LA, Krumbholz M, Ertl-Wagner B, Thaler FS, Schuh E, Metz I, Blaschek A, Dick A, Br\u00fcck W, Hohlfeld R, Meinl E, K\u00fcmpfel T (2016) Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 3(5):e257. doi: 10.1212\/NXI.0000000000000257","DOI":"10.1212\/NXI.0000000000000257"},{"issue":"3","key":"8333_CR3","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/acn3.164","volume":"2","author":"M Spadaro","year":"2015","unstructured":"Spadaro M, Gerdes LA, Mayer MC, Ertl-Wagner B, Laurent S, Krumbholz M, Breithaupt C, Hogen T, Straube A, Giese A, Hohlfeld R, Lassmann H, Meinl E, Kumpfel T (2015) Histopathology and clinical course of MOG-antibody-associated encephalomyelitis. Ann Clin Transl Neurol 2(3):295\u2013301. doi: 10.1002\/acn3.164","journal-title":"Ann Clin Transl Neurol"},{"issue":"6","key":"8333_CR4","doi-asserted-by":"publisher","first-page":"e175","DOI":"10.1212\/NXI.0000000000000175","volume":"2","author":"F Pauli Di","year":"2015","unstructured":"Di Pauli F, Hoftberger R, Reindl M, Beer R, Rhomberg P, Schanda K, Sato D, Fujihara K, Lassmann H, Schmutzhard E, Berger T (2015) Fulminant demyelinating encephalomyelitis: Insights from antibody studies and neuropathology. Neurol Neuroimmunol Neuroinflamm 2(6):e175. doi: 10.1212\/NXI.0000000000000175","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"8333_CR5","doi-asserted-by":"publisher","DOI":"10.1177\/1352458515622986","author":"S Jarius","year":"2016","unstructured":"Jarius S, Metz I, Konig FB, Ruprecht K, Reindl M, Paul F, Bruck W, Wildemann B (2016) Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in \u2018pattern II multiple sclerosis\u2019 and brain biopsy findings in a MOG-IgG-positive case. Mult Scler. doi: 10.1177\/1352458515622986 (Epub ahead of print 11 Feb 2016)","journal-title":"Mult Scler"},{"issue":"7","key":"8333_CR6","doi-asserted-by":"publisher","first-page":"480","DOI":"10.3109\/08916934.2013.796938","volume":"46","author":"RM Soares","year":"2013","unstructured":"Soares RM, Dias AT, De Castro SB, Alves CC, Evangelista MG, Da Silva LC, Farias RE, Castanon MC, Juliano MA, Ferreira AP (2013) Optical neuritis induced by different concentrations of myelin oligodendrocyte glycoprotein presents different profiles of the inflammatory process. Autoimmunity 46(7):480\u2013485. doi: 10.3109\/08916934.2013.796938","journal-title":"Autoimmunity"},{"issue":"10","key":"8333_CR7","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1093\/brain\/awh260","volume":"127","author":"H Sakuma","year":"2004","unstructured":"Sakuma H, Kohyama K, Park IK, Miyakoshi A, Tanuma N, Matsumoto Y (2004) Clinicopathological study of a myelin oligodendrocyte glycoprotein-induced demyelinating disease in LEW.1AV1 rats. Brain 127(10):2201\u20132213. doi: 10.1093\/brain\/awh260","journal-title":"Brain"},{"key":"8333_CR8","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1177\/1352458515578888","volume":"21","author":"O Outteryck","year":"2015","unstructured":"Outteryck O, Majed B, Defoort-Dhellemmes S, Vermersch P, Zephir H (2015) A comparative optical coherence tomography study in neuromyelitis optica spectrum disorder and multiple sclerosis. Mult Scler 21:1781\u20131793. doi: 10.1177\/1352458515578888","journal-title":"Mult Scler"},{"key":"8333_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/978-3-319-20970-8","volume-title":"Optical coherence tomography in multiple sclerosis","author":"O Outteryck","year":"2016","unstructured":"Outteryck O, Vermersch P (2016) OCT findings in neuromyelitis optica spectrum disorders. In: Petzold A (ed) Optical coherence tomography in multiple sclerosis, vol 1. Springer, Berlin, pp 85\u201396. doi: 10.1007\/978-3-319-20970-8"},{"issue":"4","key":"8333_CR10","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1212\/WNL.0b013e3181af78b8","volume":"73","author":"JN Ratchford","year":"2009","unstructured":"Ratchford JN, Quigg ME, Conger A, Frohman T, Frohman E, Balcer LJ, Calabresi PA, Kerr DA (2009) Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies. Neurology 73(4):302\u2013308. doi: 10.1212\/WNL.0b013e3181af78b8","journal-title":"Neurology"},{"issue":"12","key":"8333_CR11","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1212\/01.wnl.0000345042.53843.d5","volume":"72","author":"RT Naismith","year":"2009","unstructured":"Naismith RT, Tutlam NT, Xu J, Klawiter EC, Shepherd J, Trinkaus K, Song SK, Cross AH (2009) Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis. Neurology 72(12):1077\u20131082. doi: 10.1212\/01.wnl.0000345042.53843.d5","journal-title":"Neurology"},{"key":"8333_CR12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12974-015-0256-1","volume":"12","author":"AK Probstel","year":"2015","unstructured":"Probstel AK, Rudolf G, Dornmair K, Collongues N, Chanson JB, Sanderson NS, Lindberg RL, Kappos L, de Seze J, Derfuss T (2015) Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype. J Neuroinflamm 12:46. doi: 10.1186\/s12974-015-0256-1","journal-title":"J Neuroinflamm"},{"issue":"6","key":"8333_CR13","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1212\/WNL.0000000000000101","volume":"82","author":"DK Sato","year":"2014","unstructured":"Sato DK, Callegaro D, Lana-Peixoto MA, Waters PJ, de Haidar Jorge FM, Takahashi T, Nakashima I, Apostolos-Pereira SL, Talim N, Simm RF, Lino AM, Misu T, Leite MI, Aoki M, Fujihara K (2014) Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology 82(6):474\u2013481. doi: 10.1212\/WNL.0000000000000101","journal-title":"Neurology"},{"issue":"4","key":"8333_CR14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1212\/NXI.0000000000000040","volume":"1","author":"S Ramanathan","year":"2014","unstructured":"Ramanathan S, Reddel SW, Henderson A, Parratt JD, Barnett M, Gatt PN, Merheb V, Kumaran RY, Pathmanandavel K, Sinmaz N, Ghadiri M, Yiannikas C, Vucic S, Stewart G, Bleasel AF, Booth D, Fung VS, Dale RC, Brilot F (2014) Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis. Neurol Neuroimmunol Neuroinflamm 1(4):40. doi: 10.1212\/NXI.0000000000000040","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"3","key":"8333_CR15","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1001\/jamaneurol.2013.5857","volume":"71","author":"J Kitley","year":"2014","unstructured":"Kitley J, Waters P, Woodhall M, Leite MI, Murchison A, George J, Kuker W, Chandratre S, Vincent A, Palace J (2014) Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. JAMA Neurol 71(3):276\u2013283. doi: 10.1001\/jamaneurol.2013.5857","journal-title":"JAMA Neurol"},{"issue":"9","key":"8333_CR16","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/S1474-4422(10)70168-X","volume":"9","author":"A Petzold","year":"2010","unstructured":"Petzold A, de Boer JF, Schippling S, Vermersch P, Kardon R, Green A, Calabresi PA, Polman C (2010) Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol 9(9):921\u2013932. doi: 10.1016\/S1474-4422(10)70168-X","journal-title":"Lancet Neurol"},{"issue":"2","key":"8333_CR17","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O\u2019Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292\u2013302. doi: 10.1002\/ana.22366","journal-title":"Ann Neurol"},{"issue":"7","key":"8333_CR18","doi-asserted-by":"publisher","first-page":"3594","DOI":"10.4049\/jimmunol.1301296","volume":"191","author":"MC Mayer","year":"2013","unstructured":"Mayer MC, Breithaupt C, Reindl M, Schanda K, Rostasy K, Berger T, Dale RC, Brilot F, Olsson T, Jenne D, Probstel AK, Dornmair K, Wekerle H, Hohlfeld R, Banwell B, Bar-Or A, Meinl E (2013) Distinction and temporal stability of conformational epitopes on myelin oligodendrocyte glycoprotein recognized by patients with different inflammatory central nervous system diseases. J Immunol 191(7):3594\u20133604. doi: 10.4049\/jimmunol.1301296","journal-title":"J Immunol"},{"key":"8333_CR19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/7651_2015_223","volume":"1304","author":"M Spadaro","year":"2016","unstructured":"Spadaro M, Meinl E (2016) Detection of autoantibodies against myelin oligodendrocyte glycoprotein in multiple sclerosis and related diseases. Methods Mol Biol 1304:99\u2013104. doi: 10.1007\/7651_2015_223","journal-title":"Methods Mol Biol"},{"issue":"1\u20132","key":"8333_CR20","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jns.2010.01.002","volume":"291","author":"S Jarius","year":"2010","unstructured":"Jarius S, Probst C, Borowski K, Franciotta D, Wildemann B, Stoecker W, Wandinger KP (2010) Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen. J Neurol Sci 291(1\u20132):52\u201356. doi: 10.1016\/j.jns.2010.01.002","journal-title":"J Neurol Sci"},{"issue":"2","key":"8333_CR21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1177\/1352458514538110","volume":"21","author":"S Schippling","year":"2015","unstructured":"Schippling S, Balk LJ, Costello F, Albrecht P, Balcer L, Calabresi PA, Frederiksen JL, Frohman E, Green AJ, Klistorner A, Outteryck O, Paul F, Plant GT, Traber G, Vermersch P, Villoslada P, Wolf S, Petzold A (2015) Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria. Mult Scler 21(2):163\u2013170. doi: 10.1177\/1352458514538110","journal-title":"Mult Scler"},{"issue":"7","key":"8333_CR22","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1136\/jnnp-2013-306902","volume":"85","author":"LJ Balk","year":"2014","unstructured":"Balk LJ, Twisk JW, Steenwijk MD, Daams M, Tewarie P, Killestein J, Uitdehaag BM, Polman CH, Petzold A (2014) A dam for retrograde axonal degeneration in multiple sclerosis? JNNP 85(7):782\u2013789. doi: 10.1136\/jnnp-2013-306902","journal-title":"JNNP"},{"issue":"7","key":"8333_CR23","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1177\/1352458514555785","volume":"21","author":"R Hoftberger","year":"2015","unstructured":"Hoftberger R, Sepulveda M, Armangue T, Blanco Y, Rostasy K, Cobo Calvo A, Olascoaga J, Ramio-Torrenta L, Reindl M, Benito-Leon J, Casanova B, Arrambide G, Sabater L, Graus F, Dalmau J, Saiz A (2015) Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease. Mult Scler 21(7):866\u2013874. doi: 10.1177\/1352458514555785","journal-title":"Mult Scler"},{"key":"8333_CR24","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1136\/jnnp-2014-310206","volume":"87","author":"T Akaishi","year":"2016","unstructured":"Akaishi T, Sato DK, Nakashima I, Takeshita T, Takahashi T, Doi H, Kurosawa K, Kaneko K, Kuroda H, Nishiyama S, Misu T, Nakazawa T, Fujihara K, Aoki M (2016) MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study. JNNP 87:446\u2013448. doi: 10.1136\/jnnp-2014-310206","journal-title":"JNNP"},{"issue":"4","key":"8333_CR25","doi-asserted-by":"publisher","first-page":"e007766","DOI":"10.1136\/bmjopen-2015-007766","volume":"5","author":"H Nakajima","year":"2015","unstructured":"Nakajima H, Motomura M, Tanaka K, Fujikawa A, Nakata R, Maeda Y, Shima T, Mukaino A, Yoshimura S, Miyazaki T, Shiraishi H, Kawakami A, Tsujino A (2015) Antibodies to myelin oligodendrocyte glycoprotein in idiopathic optic neuritis. BMJ Open 5(4):e007766. doi: 10.1136\/bmjopen-2015-007766","journal-title":"BMJ Open"},{"key":"8333_CR26","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jneuroim.2016.02.004","volume":"293","author":"T Akaishi","year":"2016","unstructured":"Akaishi T, Nakashima I, Takeshita T, Mugikura S, Sato DK, Takahashi T, Nishiyama S, Kurosawa K, Misu T, Nakazawa T, Aoki M, Fujihara K (2016) Lesion length of optic neuritis impacts visual prognosis in neuromyelitis optica. J Neuroimmunol 293:28\u201333. doi: 10.1016\/j.jneuroim.2016.02.004","journal-title":"J Neuroimmunol"},{"issue":"8","key":"8333_CR27","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1177\/1352458512452924","volume":"18","author":"J Horssen van","year":"2012","unstructured":"van Horssen J, Witte ME, Ciccarelli O (2012) The role of mitochondria in axonal degeneration and tissue repair in MS. Mult Scler 18(8):1058\u20131067. doi: 10.1177\/1352458512452924","journal-title":"Mult Scler"},{"issue":"7","key":"8333_CR28","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1177\/1352458508091367","volume":"14","author":"F Costello","year":"2008","unstructured":"Costello F, Hodge W, Pan YI, Eggenberger E, Coupland S, Kardon RH (2008) Tracking retinal nerve fiber layer loss after optic neuritis: a prospective study using optical coherence tomography. Mult Scler 14(7):893\u2013905. doi: 10.1177\/1352458508091367","journal-title":"Mult Scler"},{"key":"8333_CR29","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1177\/1352458515593406","volume":"22","author":"S Ramanathan","year":"2016","unstructured":"Ramanathan S, Prelog K, Barnes EH, Tantsis EM, Reddel SW, Henderson AP, Vucic S, Gorman MP, Benson LA, Alper G, Riney CJ, Barnett M, Parratt J, Hardy TA, Leventer RJ, Merheb V, Nosadini M, Fung VS, Brilot F, Dale RC (2016) Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis. Mult Scler 22:470\u2013482. doi: 10.1177\/1352458515593406","journal-title":"Mult Scler"},{"issue":"Pt 1","key":"8333_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/brain\/awu335","volume":"138","author":"LJ Balcer","year":"2015","unstructured":"Balcer LJ, Miller DH, Reingold SC, Cohen JA (2015) Vision and vision-related outcome measures in multiple sclerosis. Brain 138(Pt 1):11\u201327. doi: 10.1093\/brain\/awu335","journal-title":"Brain"},{"key":"8333_CR31","doi-asserted-by":"publisher","DOI":"10.1177\/1352458515586089","author":"S Ramanathan","year":"2015","unstructured":"Ramanathan S, Sato S, Matsushita T, Masaki K, Yamasaki R, Dale RC, Kira JI, Brilot F (2015) Antibodies to myelin oligodendrocyte glycoprotein are uncommon in Japanese opticospinal multiple sclerosis. Mult Scler. doi: 10.1177\/1352458515586089","journal-title":"Mult Scler"},{"issue":"5","key":"8333_CR32","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1177\/1352458515598021","volume":"22","author":"N Hadhoum","year":"2016","unstructured":"Hadhoum N, Hodel J, Defoort-Dhellemmes S, Duhamel A, Drumez E, Zephir H, Pruvo JP, Leclerc X, Vermersch P, Outteryck O (2016) Length of optic nerve double inversion recovery hypersignal is associated with retinal axonal loss. Mult Scler 22(5):649\u2013658. doi: 10.1177\/1352458515598021","journal-title":"Mult Scler"},{"key":"8333_CR33","doi-asserted-by":"crossref","unstructured":"Zimmermann H, Pache F, Mikolajczak J, Schumacher S, Lacheta A, Jarius S, Wildemann B, Reindl M, Waldman A, Ruprecht K, Asgari N, Soelberg K, Ringelstein M, Aktas O, Paul F, Brandt AU (2016) Neuronal afferent visual system damage in MOG-antibody associated optic neuritis is as severe as in AQP4-antibody positive NMOSD (P4.275). Paper presented at the American Academy of Neurology Vancouver, April 19, 2016","DOI":"10.1212\/WNL.86.16_supplement.P4.275"},{"issue":"2","key":"8333_CR34","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1167\/iovs.13-12912","volume":"55","author":"MC Burggraaff","year":"2014","unstructured":"Burggraaff MC, Trieu J, de Vries-Knoppert WA, Balk L, Petzold A (2014) The clinical spectrum of microcystic macular edema. IOVS 55(2):952\u2013961. doi: 10.1167\/iovs.13-12912","journal-title":"IOVS"},{"issue":"15","key":"8333_CR35","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1212\/WNL.0b013e31828c2f7a","volume":"80","author":"ES Sotirchos","year":"2013","unstructured":"Sotirchos ES, Saidha S, Byraiah G, Mealy MA, Ibrahim MA, Sepah YJ, Newsome SD, Ratchford JN, Frohman EM, Balcer LJ, Crainiceanu CM, Nguyen QD, Levy M, Calabresi PA (2013) In vivo identification of morphologic retinal abnormalities in neuromyelitis optica. Neurology 80(15):1406\u20131414. doi: 10.1212\/WNL.0b013e31828c2f7a","journal-title":"Neurology"},{"issue":"Pt 12","key":"8333_CR36","doi-asserted-by":"publisher","first-page":"e226","DOI":"10.1093\/brain\/aws216","volume":"135","author":"LJ Balk","year":"2012","unstructured":"Balk LJ, Killestein J, Polman CH, Uitdehaag BM, Petzold A (2012) Microcystic macular oedema confirmed, but not specific for multiple sclerosis. Brain 135(Pt 12):e226. doi: 10.1093\/brain\/aws216 (author reply e227)","journal-title":"Brain"},{"issue":"Pt 6","key":"8333_CR37","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1093\/brain\/aws098","volume":"135","author":"JM Gelfand","year":"2012","unstructured":"Gelfand JM, Nolan R, Schwartz DM, Graves J, Green AJ (2012) Microcystic macular oedema in multiple sclerosis is associated with disease severity. Brain 135(Pt 6):1786\u20131793. doi: 10.1093\/brain\/aws098","journal-title":"Brain"},{"issue":"11","key":"8333_CR38","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/S1474-4422(12)70213-2","volume":"11","author":"S Saidha","year":"2012","unstructured":"Saidha S, Sotirchos ES, Ibrahim MA, Crainiceanu CM, Gelfand JM, Sepah YJ, Ratchford JN, Oh J, Seigo MA, Newsome SD, Balcer LJ, Frohman EM, Green AJ, Nguyen QD, Calabresi PA (2012) Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study. Lancet Neurol 11(11):963\u2013972. doi: 10.1016\/S1474-4422(12)70213-2","journal-title":"Lancet Neurol"},{"issue":"3","key":"8333_CR39","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/ana.24351","volume":"77","author":"I Gabilondo","year":"2015","unstructured":"Gabilondo I, Martinez-Lapiscina EH, Fraga-Pumar E, Ortiz-Perez S, Torres-Torres R, Andorra M, Llufriu S, Zubizarreta I, Saiz A, Sanchez-Dalmau B, Villoslada P (2015) Dynamics of retinal injury after acute optic neuritis. Ann Neurol 77(3):517\u2013528. doi: 10.1002\/ana.24351","journal-title":"Ann Neurol"},{"key":"8333_CR40","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1177\/1352458515590646","volume":"22","author":"OA Al-Louzi","year":"2016","unstructured":"Al-Louzi OA, Bhargava P, Newsome SD, Balcer LJ, Frohman EM, Crainiceanu C, Calabresi PA, Saidha S (2016) Outer retinal changes following acute optic neuritis. Mult Scler 22:362\u2013372. doi: 10.1177\/1352458515590646","journal-title":"Mult Scler"},{"issue":"1","key":"8333_CR41","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ophtha.2013.08.045","volume":"121","author":"M Abegg","year":"2014","unstructured":"Abegg M, Dysli M, Wolf S, Kowal J, Dufour P, Zinkernagel M (2014) Microcystic macular edema: retrograde maculopathy caused by optic neuropathy. Ophthalmology 121(1):142\u2013149. doi: 10.1016\/j.ophtha.2013.08.045","journal-title":"Ophthalmology"},{"issue":"7","key":"8333_CR42","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1007\/s00415-016-8147-7","volume":"263","author":"M Sep\u00falveda","year":"2016","unstructured":"Sep\u00falveda M, Armangue T, Martinez-Hernandez E, Arrambide G, Sola-Valls N, Sabater L, T\u00e9llez N, Midaglia L, Ari\u00f1o H, Peschl P, Reindl M, Rovira A, Montalban X, Blanco Y, Dalmau J, Graus F, Saiz A (2016) Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes. J Neurol 263(7):1349\u20131360. doi: 10.1007\/s00415-016-8147-7","journal-title":"J Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-016-8333-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-016-8333-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-016-8333-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T15:20:47Z","timestamp":1718896847000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-016-8333-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,14]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["8333"],"URL":"https:\/\/doi.org\/10.1007\/s00415-016-8333-7","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,14]]}}}